iRhythm Technologies (IRTC) Competitors $104.78 +2.14 (+2.08%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$104.21 -0.57 (-0.54%) As of 08:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. SNN, SOLV, PEN, STVN, GKOS, NARI, INSP, BLCO, SLNO, and TMDXShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Smith & Nephew Solventum Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Soleno Therapeutics TransMedics Group iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew (NYSE:SNN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, analyst recommendations, media sentiment, community ranking, risk, institutional ownership and dividends. Do institutionals & insiders hold more shares of IRTC or SNN? 25.6% of Smith & Nephew shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Do analysts prefer IRTC or SNN? iRhythm Technologies presently has a consensus price target of $119.73, suggesting a potential upside of 14.27%. Smith & Nephew has a consensus price target of $27.00, suggesting a potential upside of 0.00%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe iRhythm Technologies is more favorable than Smith & Nephew.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82Smith & Nephew 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings and valuation, IRTC or SNN? Smith & Nephew has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$591.84M5.65-$123.41M-$3.64-28.79Smith & Nephew$5.81B2.04$263M$2.1612.50 Which has more volatility & risk, IRTC or SNN? iRhythm Technologies has a beta of 1.45, suggesting that its share price is 45% more volatile than the S&P 500. Comparatively, Smith & Nephew has a beta of 0.71, suggesting that its share price is 29% less volatile than the S&P 500. Does the MarketBeat Community favor IRTC or SNN? Smith & Nephew received 40 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.07% of users gave iRhythm Technologies an outperform vote while only 54.29% of users gave Smith & Nephew an outperform vote. CompanyUnderperformOutperformiRhythm TechnologiesOutperform Votes40966.07% Underperform Votes21033.93% Smith & NephewOutperform Votes44954.29% Underperform Votes37845.71% Is IRTC or SNN more profitable? Smith & Nephew has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Smith & Nephew's return on equity of 0.00% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-19.14% -118.83% -11.34% Smith & Nephew N/A N/A N/A Does the media favor IRTC or SNN? In the previous week, iRhythm Technologies and iRhythm Technologies both had 7 articles in the media. Smith & Nephew's average media sentiment score of 1.69 beat iRhythm Technologies' score of 1.41 indicating that Smith & Nephew is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Very Positive SummarySmith & Nephew beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.34B$4.25B$5.40B$7.70BDividend YieldN/A46.48%5.44%4.32%P/E Ratio-28.7929.7422.1918.33Price / Sales5.6551.39401.45107.05Price / CashN/A51.0838.2034.62Price / Book15.306.076.834.25Net Income-$123.41M$67.09M$3.20B$247.51M7 Day Performance3.78%4.09%5.92%6.33%1 Month Performance-1.71%-8.66%-4.20%-3.33%1 Year Performance-5.83%27.44%17.87%5.15% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.0416 of 5 stars$104.78+2.1%$119.73+14.3%-10.0%$3.34B$591.84M-28.791,790Upcoming EarningsPositive NewsSNNSmith & Nephew2.5079 of 5 stars$25.71-0.8%$27.00+5.0%+9.9%$11.24B$5.81B11.9020,100News CoverageSOLVSolventum1.6266 of 5 stars$64.08-3.3%$79.86+24.6%+6.3%$11.09B$8.25B23.3022,000Positive NewsPENPenumbra4.1927 of 5 stars$270.53-2.5%$293.93+8.7%+44.7%$10.47B$1.19B795.683,900Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsGap UpSTVNStevanato Group1.415 of 5 stars€21.65-1.0%N/A-20.0%$6.56B$1.10B46.064,650GKOSGlaukos4.5929 of 5 stars$88.17-2.3%$156.17+77.1%-5.8%$4.99B$383.48M-30.72780Upcoming EarningsNARIInari Medical0.659 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800Upcoming EarningsPositive NewsINSPInspire Medical Systems4.685 of 5 stars$144.74-3.6%$218.90+51.2%-32.5%$4.31B$802.80M83.67760Gap UpBLCOBausch + Lomb3.9445 of 5 stars$12.05-0.1%$18.82+56.2%-6.7%$4.26B$4.79B-13.2412,500Upcoming EarningsAnalyst ForecastGap UpSLNOSoleno Therapeutics4.8179 of 5 stars$68.93-1.5%$99.63+44.5%+88.7%$3.16BN/A-20.7630Analyst ForecastPositive NewsTMDXTransMedics Group2.6845 of 5 stars$87.72-0.6%$122.70+39.9%+6.0%$2.97B$441.54M93.32210Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Smith & Nephew Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Inari Medical Alternatives Inspire Medical Systems Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives TransMedics Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
